ILEVRO® (nepafenac ophthalmic suspension) 0.3%
A PRODRUG NSAID
FOR CATARACT SURGERY:
PUT POTENCY PRECISELY
WHERE YOU NEED IT
Technology
Inflammation Clearing
Ocular Pain
Safety
Dosing
Resources

Designed Differently

ILEVRO® Suspension has higher concentration3, increased viscosity3, and smaller particle size than NEVANAC® Suspension3

US-ILV-16-E-0142a

ILEVRO® Suspension has higher concentration3, increased viscosity3, and smaller particle size than NEVANAC® Suspension3

ILEVRO® Suspension
is the only prodrug NSAID formulated specifically for once-daily post-op use

  • ILEVRO® Suspension is dosed once daily post-op compared with 3x daily for NEVANAC® (nepafenac ophthalmic suspension) 0.1%1,2
    • ILEVRO® Suspension is administered once daily beginning 1 day prior to surgery through 14 days post-surgery, with an additional drop administered 30 to 120 minutes prior to surgery1
    • Use of ILEVRO® Suspension more than 1 day prior to surgery or use beyond 14 days post-surgery may increase patient risk and severity of corneal adverse events1
  • ILEVRO® Suspension contains 3x the concentration of active ingredient compared with NEVANAC® Suspension1,2
  • The vehicle for ILEVRO® Suspension contains guar gum to increase viscosity3
 
ILEVRO® Suspension has higher concentration3, increased viscosity3, and smaller particle size than NEVANAC® Suspension3

ILEVRO® Suspension has higher concentration3, increased viscosity3, and smaller particle size than NEVANAC® Suspension3

ILEVRO® Suspension puts potency precisely where you need it